Find comprehensive information on Cataract Extraction, also known as Cataract Surgery and Lens Replacement Surgery. This resource covers essential details for healthcare professionals, including clinical documentation requirements, medical coding for Cataract Extraction (ICD-10, CPT), postoperative care, and lens implant options. Learn about diagnosis, treatment, and billing best practices for Cataract Surgery to optimize patient care and ensure accurate medical records.
Clouding of the eye's natural lens, affecting vision.
Blurred vision, glare, halos, faded colors, poor night vision.
Outpatient surgical centers, ophthalmology clinics, hospitals.
Complete code families applicable to Z98.49
| Description | When to use |
|---|---|
| Clouded eye lens causing blurry vision. | Primary diagnosis for surgical removal of a cataract. Use for all types of cataract surgery. |
| Complication arising after cataract surgery. | Use for complications like Posterior Capsule Opacification (PCO), infection, or inflammation following cataract extraction. |
| Age-related or congenital lens clouding without surgery. | Diagnose when a cataract is present but surgery has not been performed. Specify type if known (e.g., nuclear, cortical). |
Missing or incorrect laterality (right, left, bilateral) can lead to claim denials or inaccurate reimbursement.
Unspecified or incorrect coding of extracapsular vs. intracapsular or phacoemulsification impacts payment.
Failure to code coexisting conditions like glaucoma or diabetic retinopathy affects severity and reimbursement.
Verify visual acuity impairment documented (ICD-10 H25.x, H26.x)
Confirm pre-op exam and informed consent completed
Check IOL power calculations and lens selection documented
Ensure patient allergies and medications are reviewed
Verify surgical site marked correctly (laterality)
Patient presents for cataract extraction evaluation due to progressively worsening blurred vision, glare, and halos, impacting activities of daily living such as reading and driving. Symptoms are consistent with a diagnosis of cataracts, confirmed by slit-lamp examination revealing lens opacification in the (right eye, left eye, or both eyes - specify). Visual acuity is (document Snellen chart findings for each eye). The patient's medical history includes (list relevant medical conditions such as diabetes, hypertension, or previous eye surgeries). Current medications include (list all current medications). Allergies include (list any known allergies). Surgical intervention in the form of phacoemulsification with intraocular lens implantation is recommended and discussed with the patient, including risks, benefits, and alternatives such as continued conservative management with updated refractive correction. Patient understands the treatment plan and consents to proceed with cataract surgery. Preoperative instructions provided, including necessary eye drops and fasting guidelines. Scheduled for (type of anesthesia) cataract surgery on (date) at (time). ICD-10 code H26.9 (unspecified cataract) or other relevant specific cataract code assigned. CPT code for phacoemulsification with IOL insertion will be determined based on the specific lens implanted and surgical technique employed. Follow-up appointment scheduled for postoperative evaluation.
Posterior Capsule Opacification (PCO) remains a common complication following cataract surgery. While the use of square-edged IOLs and meticulous surgical technique during anterior vitrectomy can significantly reduce PCO incidence, post-operative management also plays a crucial role. Studies suggest that optimizing patient education on proper eye drop administration and adherence to the prescribed regimen can minimize inflammation and cellular proliferation on the posterior capsule. Explore how incorporating novel anti-inflammatory drug delivery systems, alongside advancements in IOL biomaterials, can further enhance PCO prevention strategies. Consider implementing a structured follow-up schedule with detailed posterior capsule assessment to facilitate early detection and intervention for PCO, such as Nd:YAG laser capsulotomy if clinically indicated.
Distinguishing between expected post-operative inflammation and the more serious complication of endophthalmitis requires careful clinical evaluation. While mild discomfort and slight redness can occur in the days following cataract surgery, any significant increase in pain, decreased vision, photophobia, or marked conjunctival injection should raise suspicion for endophthalmitis. A thorough examination including assessment of anterior chamber cells and flare, vitreous haze, and measurement of intraocular pressure is essential. In cases with atypical presentation or concerning findings, consider obtaining anterior chamber paracentesis for culture and sensitivity to rule out infection. Learn more about the latest diagnostic criteria and evidence-based management protocols for post-cataract surgery endophthalmitis to ensure prompt and appropriate intervention.
Selecting the optimal IOL requires a personalized approach considering the patient's unique characteristics. Factors such as occupation, hobbies, and desired visual outcomes influence the choice between monofocal, multifocal, toric, or extended depth of focus IOLs. For patients with pre-existing astigmatism, toric IOLs can effectively correct corneal astigmatism, reducing the need for post-operative spectacles. In patients with dry eye syndrome, careful consideration should be given to the IOL material and design, as certain materials may exacerbate dry eye symptoms. Explore how advancements in IOL technology, including hydrophilic and hydrophobic acrylic IOLs, can be tailored to the individual needs of patients with specific ocular comorbidities to optimize visual outcomes and patient satisfaction after cataract extraction.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.